NOT KNOWN FACTS ABOUT MRTX1133 STRUCTURE

MRTX1133 is an exceptionally powerful and selective KRASG12D inhibitor. It optimally fills the swap II pocket and extends three substituents to favorably connect with the protein. The KA further potential benefit of combining KRAS inhibitors and checkpoint inhibitors is that these drugs “operate by wholly distinctive mechanisms,” Dr. Luo said.